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ABSTRACT: There is now crucial medical importance placed on understanding the role of early-stage, sub-visible protein 
aggregation, particularly in neurodegenerative disease. While there are strategies for detecting such aggregates in vitro, 
there is no approach at present that can detect these toxic species associated with cells and specific subcellular compart-
ments. We have exploited excitation-energy-dependent fluorescence edge-shift of recombinant protein labelled with a mo-
lecular beacon, to provide a sensitive read out for the presence of sub-visible protein aggregates. To demonstrate the po-
tential utility of the approach we examine the major peptide associated with the initiation of Alzheimer’s disease, amyloid 
β-protein (Aβ) at a patho-physiologically relevant concentration in mouse cortical neurons. Using our approach, we find 
preliminary evidence that sub-visible Aβ aggregates are detected at specific subcellular regions and that neurons drive the 
formation of specific Aβ aggregate conformations. These findings therefore demonstrate the potential of a novel fluores-
cence-based approach for detecting and imaging protein aggregates in a cellular context, which can be used to sensitively 
probe the association of early-stage toxic protein aggregates within subcellular compartments.
Neurodegenerative disorders, such as Alzheimer’s dis-
ease (AD), are major pathological issues facing aging pop-
ulations across the world. These diseases typically arise co-
incident with the appearance and deposition of hallmark 
protein aggregates, many of which are thought to be toxic 
to neurons.1 Amyloid β-protein (Aβ) is the major peptide 
component of senile plaques found in AD, and the present 
consensus view is that early stage, sub-visible (<1 μm) ag-
gregates composed of small oligomers of Aβ are the likely 
toxic species.2,3 Formation of these early-stage aggregates 
are thought to promote further aggregation, leading to fi-
brillation of the protein.1 Early-stage Aβ aggregates can be 
tracked in isolation for example using FRET based-assays4 
and late-stage fibrillar aggregates can be monitored in cell-
based or tissue assays.5 A range of approaches have been 
developed for the purpose of capturing increasingly small 
and early stage protein aggregates, for example emerging 
super resolution,6 FRET-based sensor7 and single molecule 
approaches.8,9 
However, there is presently no strategy for monitoring 
and quantifying the extent of pre-fibrillar, soluble Aβ ag-
gregates associated with cells and in different sub-cellular 
compartments. Being able to visualize these early stage 
toxic species within their cellular context would dramati-
cally enhance our ability to understand the molecular 
mechanisms underlying the development and progression 
of AD. 
Excitation-energy-dependent changes in fluorophore 
emission are most commonly reported as the red-edge ex-
citation shift (REES).10-13 That is, the fluorescence emission 
spectrum of a fluorophore shows a shift in the peak maxi-
mum and inhomogeneous broadening of the spectra upon 
decreasing excitation energy.11,12 This shift is observed in 
situations where, after photo-excitation, the solvent relax-
ation is slow relative to the emission of the fluorophore. 
This leads to emission from a lower level excited state, 
shifting the emission to lower energies.  When decreasing 
the excitation energy, discrete emission states are photo-
selected, resulting in a red-shift of the emission spectrum 
with respect to excitation wavelength.10-14 The REES phe-
nomenon has been observed in biomolecules both with in-
trinsic and extrinsic fluorophores.14-19 Less commonly ob-
served is a blue-shift in the emission spectrum with de-
creasing excitation energy, however, this may be explained 
by upward orientational relaxation of the environment.20 
These concepts are shown in Figure 1A. Experimentally, 
one measures the combined excitation/emission (EEM) 
spectrum and plots the change in the center of spectral 
mass (CSM) of the emission spectra, versus the change in 
excitation wavelength (ΔλEx). 
Edge-shift phenomena have been shown to be accurate 
probes of subtle protein conformational change (for exam-
ple refs 14-18), and we have recently shown sensitivity to 
changes in the proteins free energy landscape.15 Given 
 
  
Figure 1. A, Ground and excited electronic states demonstrated by the orientational coordinates of their zero vibrational 
levels.  Relaxation along the potential curve to the energy minimum leads to photo-selected emission causing a red-shift, or 
blue-shift for up-relaxation. B, Edge-shift measurements of monomeric (red and green) and aggregated (blue and yellow) 
Rituximab and Nivolumab labelled with Alexa-488. Inset, DLS profiles for monomeric (black dashed line) and aggregated 
mAbs (colors as main panel). 
this sensitivity, we reasoned that early-stage, amorphous 
protein aggregates would similarly reflect highly complex 
fluorophore environments. As such, an extrinsic fluoro-
phore label, acting as a molecular beacon, might prove sen-
sitive to aggregate formation when measuring edge-shift. 
Such a probe would then allow the formation of early stage 
aggregates to be imaged.  
Herein, we demonstrate that the fluorescence edge-shift 
phenomenon can be used to monitor the formation of early 
stage, sub-visible Aβ aggregates (< ~1 μm). We detect these 
species in cultured neurons exposed to nanomolar concen-
trations of a model peptide fragment21 responsible for Aβ 
aggregation (Aβ15-21) as well as near full length peptide 
(Aβ1-40) and imaged using high resolution microscopy. 
We find evidence that sub-visible Aβ aggregates associate 
with discrete subcellular compartments of the neuron, 
likely due to the presence of specific Aβ binding sites or the 
influence of the local cellular environment on the for-
mation of a particular Aβ species. Moreover, our data point 
to the importance of considering Aβ aggregation in the 
presence of a relevant cellular model and that potentially 
neurons themselves drive the Aβ aggregation type. Our 
findings present a new approach for monitoring the for-
mation and interaction of toxic Aβ species with a relevant 
cellular model system, but also point to a new tool that 
could be used much more widely to augment basic re-
search and drug development into other neurodegenera-
tive diseases that are driven by protein aggregation. 
RESULTS AND DISCUSSION  
Antibodies are particularly prone to aggregation and can 
easily be driven to early stage aggregates through low tem-
perature incubation. Therefore, we wished to use these 
species as model systems to explore whether protein aggre-
gation could be detected sensitively by extrinsic fluoro-
phore edge-shift. We have labelled two therapeutic mono-
clonal antibodies (mAbs), Rituximab and Nivolumab, with 
either the fluorophores Alexa 488 or fluorescein via a ma-
leimide linkage to solvent exposed cysteine residues (Fig-
ure S1).  
Absorption spectra (Figure S1A-C) show that essentially 
0.5 molar equivalents of either dye binds to the mAbs un-
der the conditions we use. Figures S1D-I show the emission 
spectra for each dye-labelled mAb in both monomeric (Fig-
ure S1G-I) and aggregated states (Figure S1G-I). The result-
ing edge-shift data are shown in Figure 1B for the Alexa488 
mAbs and in Figure S2 for the fluorescein labelled mAb. 
Figure 1B inset, shows dynamic light scattering (DLS) data 
for the mAbs, providing independent evidence that the 
thermally treated mAbs have formed sub-visible aggre-
gates. From Figure 1B we find that the native, non-aggre-
gated protein displays no edge-shift across the excitation 
range studied. However, we find on thermal aggregation of 
the mAbs, for both Alexa 488 and fluorescein, there is a 
clear blue-shift in the emission spectra (Figure 1B and S2). 
Moreover, the trend is the same with two different fluoro-
phores, demonstrating our observation is not an artefact of 
a specific dye structure. The excitation spectra are essen-
tially invariant across the emission range studied, for both 
the monomeric and aggregated mAbs as shown in Figure 
S1J-L, demonstrating that the observed edge-shift does not 
have an artefactual cause. 
The monomeric mAb labelled with fluorescein shows 
some blue-shift in its emission spectra (Figure S2). How-
ever, the overall magnitude is far smaller than that ob-
served for the aggregated protein. From Figure 1B, the data 
show that the magnitude of the blue-shift plateaus as the 
aggregates tend towards visible particles (>1 μm). Based on 
the observed changes the observed edge shift appear to sat-
urate towards aggregates in the ~100mer region. Therefore, 
these data suggest that the blue-shift is primarily sensitive 
  
 
Figure 2.  Variation in CSM of Alexa 488 versus change in dielectric constant of solvent where dielectric is changed by (A (0% 
MeOH), B (70% MeOH)), temperature or (C (10 ˚C), D (50 ˚C)) methanol concentration. Alexa 488 emission was measured in 
water and methanol/water mixtures at 405, 450, and 532 nm.  The laser lines were subtracted from the spectra, and a skewed 
Gaussian was fit to the data.  CSM values were calculated from the fitted emission spectra.  The difference was then taken between 
the CSMs of 450 and 405 nm, and 532 and 450 nm to give ΔCSM. The dashed-lines are to aid the eye only. 
to the formation of sub-visible aggregates and we corrobo-
rate this finding below. We note that a recent study has 
shown that a red edge-shift is observed on aggregation of 
κ-casein as it forms amyloid fibrils, based on tryptophan 
emission.22 The edge-shift phenomenon is sensitive to 
changes in the dipole moment of the environment and so 
we suggest that whether a red or blue shift is observed is 
based in large part on the specifics of the aggregation type 
and environment, which controls the dipole moment of 
the fluorophore. We explore this in more detail below. 
Excitation energy-dependent spectral shifts are most 
commonly observed as a red-shift in emission spectra, 
though blue-shifts have been previously characterized.20 
Therefore, we turned to free fluorophore solution studies 
using laser-based excitation to confirm the blue-shift we 
observe in Figure 1B is responsive to environmental relaxa-
tion (Figure 1A), i.e. that it is a bone fide excitation-energy-
dependent edge-shift. Figure S3A-B shows that Alexa 488, 
free in buffered solution, gives both a blue- and a red-shift 
with increasing excitation wavelength. Figure S3C-E shows 
that these shifts are not attributable to the differential ab-
sorption of the excitation light at different excitation wave-
lengths, and are not due to the bandwidth of the excitation.  
Edge-shift phenomena are based on slow dipolar relaxa-
tion of the solvent environment. Therefore, altering the 
solvent dipole should induce a change in the observed ex-
citation energy-dependent edge-shift. Given the potential 
to observe either a red or a blue shift in excitation energy 
dependent fluorescence emission, we have conducted sol-
vent studies to determine the dependence of a fluorophore 
on changes in environment (dielectric). We altered the sol-
vent dipole by two independent methods, through varying 
methanol concentration and temperature, and the result-
ing effect on the observed edge-shift from Figure S3A/B is 
shown in Figure 2A-D.  When using 0 % methanol, the di-
electric constant was reduced through increasing temper-
ature, and was found to give a blue-shift for the ΔCSM val-
ues of 450 and 405 nm.  A red-shift was observed for 532 
and 450 nm (Figure 2A).   However, when changing the 
solvent system for 70 % methanol, a red-shift was observed 
for the ΔCSM of 450 and 405 nm, and a blue-shift for 532 
and 450 nm (Figure 2B). At 10 and 50 ˚C, the dielectric con-
stants were decreased by increasing methanol concentra-
tion. When measuring the ΔCSMs at 10 ˚ C, a blue- shift was 
observed for 450 and 405 nm, and a red-shift for 532 and 
450 nm (Figure 2C).  This trend was inverted when the
   
Figure 3. A, Edge-shift measurements demonstrating sensitivity between monomerized and aggregated states (shown as 
differently colored data points) of fluor-Aβ15-21 and coloration is correlated between main panel and inset. The black dashed-
line shows the data for fluorescein alone. Inset, DLS data for monomerized and aggregated fluor-Aβ15-21. Coloration corre-
sponds to aggregation state shown in inset. B, Correlation between the change in CSM (ΔCSM) for fluor-Aβ15-21 shown in 
Panel A.  The Z-average hydrodynamic diameter from the DLS data shown in Panel A. Coloration is as Panel A. 
temperature was increased to 50 ˚C, showing a red-shift 
and blue-shift for ΔCSMs of 450 and 405 nm, and 532 and 
450 nm, respectively (Figure 2D). The dielectric constants 
of the methanol/water mixtures were calculated as de-
scribed by Andrenko and Wang23 and correlated with the 
experimental data by Gosting and Albright.24  
We find that both the blue- and red-shift (Figure S3E) are 
sensitive to changes in the dielectric constant of the sol-
vent (Figure 2A-D). Figure S4 shows that these shifts are 
not due to differences in the absorption spectrum when 
varying methanol concentrations. From Figure 2, decreas-
ing the dielectric constant gave rise to an inversion of the 
blue- and red-shifts. That is, the observed blue-shift be-
comes a red-shift and the observed red-shift becomes a 
blue-shift. These data are convincing evidence that the two 
edge-shifts arise from the same physical phenomenon, i.e. 
excitation-energy-dependent fluorescence edge-shift, as 
shown in Figure 1A. Moreover, these data suggest that a 
plausible mechanism for the large blue-shift, associated 
with the protein aggregation we observe above, are differ-
ences in the dipolar relaxation of the environment around 
the fluorophore on aggregate formation. We suggest this is 
because the early-stage aggregates are potentially amor-
phous, and the molecular beacon experiences a range of 
different molecular (dipolar) environments. This would ex-
plain the relative insensitivity to larger, structured aggre-
gates that are essentially a homogenous repeating unit.  
Moreover, these data suggest that the same fluorophore 
can experience either a red or blue shift depending on 
changes in the local dielectric and this finding validates our 
finding of a blue edge-shift on protein aggregation (Figure 
1B) and the observation of a red-shift for a different protein 
and fluorophore combination. We stress that our analysis 
does not at this point allow us to definitively assign the 
morphology and structure of aggregates, simply that we 
are detecting sub-visible aggregates. 
Having established that the observed edge-shift is bone 
fide and provides a measurement of the presence of sub-
visible protein aggregates in the mAb model systems, we 
sought to apply the approach to a biomedically important 
system where the formation of small soluble aggregates are 
relevant. Therefore, we synthesized the peptide fragment 
of Aβ that is responsible for the formation of toxic aggre-
gates of the protein, Aβ15-21 (QKLVFFA). This peptide has 
previously been used as a model for the full length Aβ25 and 
has some advantages in the tractability of synthesis. The 
peptide was synthesized with an N-terminal fluorescein 
(fluor-Aβ15-21) to monitor the change in edge-shift on aggre-
gation of the peptide. We opted for the fluorescein label 
since labelling large quantities of peptide with Alexa 488 
would be prohibitively expensive for most researchers, and 
we would like others to be able to adopt this approach. 
Figure 3A shows the observed edge-shift for monomerized 
and aggregated fluor-Aβ15-21 peptides and the correspond-
ing raw emission and excitation spectra are shown in Fig-
ure S5A/B and S5C, respectively. Peptide aggregates were 
obtained by ageing the monomerized sample at room tem-
perature and then separation by FPLC. Similar to the mAbs 
studied above, the excitation spectra essentially overlay at 
all emission wavelengths for the monomeric and aggre-
gated protein (Figure S5C). Figure 3A inset shows the cor-
responding DLS profiles, showing the relative aggregation 
state of the samples. The ability of fluor-Aβ15-21 to form am-
yloid-like fibrillar aggregates is confirmed by the binding 
of thioflavin-T (ThT), giving an increase in ThT emission 
(Figure S6).26 However, we note that the aggregates we ob-
serve e.g. in Figure 3 are small and we suggest pre-fibrillar 
as we discuss below. Similar to the monomeric mAbs la-
belled with fluorescein, we observe a significant blue-shift 
associated with the monomeric fluor-Aβ15-21. However, 
again similar to the fluorophore labelled mAb, the absolute 
magnitude of the edge-shift is small for the monomer (0.04 
nm/nm) compared to the aggregated peptide (0.11 
nm/nm).  
Figure 3B shows the correlation between the absolute 
magnitude of the observed edge-shift versus the change in
  
Figure 4. Mouse cortical neurons (‘Cell 1’, Panel A and ‘Cell 2’, Panel B) treated with 500 nM Aβ15-21-fluor, analyzed by high resolu-
tion fluorescence microscopy. Labels i-iv show specific morphological features, likely corresponding to the cell body (i), dendrite 
(ii) periaxonal region (iii) and synapses (iv).  C and D show the corresponding false color map of ΔCSM = CSM λEx514nm - CSM 
λEx458nm extracted from emission spectra of each image.  
the intensity weighted aggregate size for fluor-Aβ15-21. 
These data suggest, similar to the mAb data in Figure 1B 
that the magnitude of the edge-shift increases with the 
fraction of protein aggregate, but saturates as the aggre-
gates tend towards visible (>1 μm). From Figure 3B it ap-
pears the edge-shift is most sensitive to relatively small ag-
gregates, with highest sensitivity to hydrodynamic diame-
ters on the low nanometer range (Figure 3A, inset). Such a 
size would correspond to low n oligomers of fluor-Aβ15-21 ~ 
10-100 mers, similar to the approximate size with the mAbs 
above (Figure 1B). We note that centrifugation does not 
yield a measureable pellet.  and the aggregates we monitor 
are entirely soluble. Indeed, tThe blue-shift appears to sat-
urateapparent saturation of the observed blue-shift (Figure 
3B) as the aggregates approach visible sizes (Figure 3A in-
set), suggestings that the approach is insensitive to large (> 
1 μm) aggregates that are classically captured by ThT as-
says. We suggest the reason for this insensitivity is because 
the late-stage fibrillar form of Aβ is essentially a homoge-
nous repeating unit, and the edge-shift phenomenon is 
based on detecting sample heterogeneity where discrete 
states can be photo-selected. The sensitivity to the earliest 
stages of Aβ aggregates is important since it is the early 
stage aggregates that are considered to be the toxic species 
in AD.3 Again we stress that at present we cannot defini-
tively determine the aggregation morphology (e.g fibrillary 
or not) based on the edge-shift value, simply the overall 
hydrodynamic diameter. 
Having established that the observed edge-shift can be 
used to track sub-visible protein aggregates, and that are 
relevant to Aβ toxicity, we wished to ask if edge-shift could 
be observed and quantified using a microscope platform 
and applied to cell studies. We cultured mouse primary 
cortical neurons (reflecting a key region of the brain af-
fected by AD) for 7 days27 and incubated the differentiated 
cells for 24 hours with a concentration of fluor-Aβ15-21 that 
is within the range typically used for pathophysiological 
studies in vitro (500 nM).28 The presence of fluor-Aβ15-21 
gave rise to significant morphological changes to the neu-
rons, potentially indicative of neuro-toxicity as expected 
(Figure S7).  The neurons were then washed with phos-
phate buffered saline (PBS) to remove non-bound fluor-
Aβ15-21  and fixed with 4% paraformaldehyde.  Paraformal-
dehyde does not affect the absolute magnitude of the ob-
served edge-shift giving, 0.039 nm/nm and 0.036 nm/nm 
for the untreated and paraformaldehyde treated fluor-Aβ15-
21, respectively. 
Figures 4A (Cell 1) and 2B (Cell 2) show examples of neu-
rons with different morphologies. Cell 1 shows a large dis-
crete cell body, proximal axons, and a dendritic network. 
Cell 2 shows a much more extensive and elaborate den-
dritic network, allowing better quantification of the edge-
shift with respect to synaptic localization. We note that 
these assignments are based on the morphology of the cells 
and not confirmed by cell marker staining, due to the con-
cern that introducing another dye molecule may affect the 
emission characteristics of the fluor-Aβ15-21 through either 
resonance energy transfer (RET) or direct collisional
  
 
Figure 5. A, Edge-shift measurements demonstrating sensitivity between monomerized and aggregated states of fluor-Aβ1-40 that 
have been aged for different time periods (inset) at 25 °C. The black dashed-line shows the data for fluorescein alone. Inset, DLS 
data for monomerized and aggregated fluor-Aβ1-40. Coloration corresponds to time points in inset. B, Correlation between the 
change in CSM (ΔCSM) for fluor-Aβ1-40 shown in Panel A.  The Z-average hydrodynamic diameter from the DLS data shown in 
Panel A. Coloration is as Panel A. 
quenching. At present we are not aware of any study that 
details the optical physics of such interactions relating spe-
cifically to edge-shift phenomena and so we have been re-
luctant to convolve the present data set with this unknown. 
That said, our study aims to illustrate the potential of the 
approach and to establish the routes to and limitations of 
its use.  
To extract the cellular CSM versus λEx profile, we moni-
tored the EEM spectra of the fixed cells using a Leica SP8 
confocal microscope with spectral detection across the ex-
citation range of 405-514 nm. Figures 4C and 4D show the 
processed EEM data to give the absolute magnitude of the 
blue-shift as the difference in CSM between λEx 458 and 516 
nm, and were overlaid as a false color image onto the cor-
responding fluorescence image from Figures 4A and 4B. 
CSMs were calculated on a per pixel basis after smoothing 
with a Gaussian filter with a 6 pixel FWHM diameter. The 
coloration is based on the absolute magnitude of the ob-
served blue-shift. The control experiment with fluorescein 
imaged alone is shown in Figure S8, giving a total edge-
shift of ~1 nm between λEx 458-516 nm. From Figure 4C and 
4D, we find that the magnitude of the blue-shift varies sig-
nificantly depending on the cellular morphology. Zoomed 
in views of the subcellular regions in Figure 4A and 4B are 
shown in Figure S9. 
The cell body evident in Figure 4A shows essentially no 
edge-shift, consistent with the measurement from fluores-
cein alone (Figure S9). A larger edge-shift is observed for 
the axons and dendrites in both Figure 4C and 4D (Figure 
S9). Without staining it is difficult to definitively identify 
synaptic structures. However, in many cases we find that 
the likely locations of synapses and terminals, based on 
morphology, is coincident with very high magnitudes of 
measured edge-shift (Figure S9). Indeed, we selected Cell 
2 because of its extensive dendritic network where we an-
ticipate a large number of synapses will be located. Cell 2 
shows a globally larger edge-shift compared to Cell 1, which 
has a rather less developed dendritic structure. From Fig-
ure 3 we find that, for fluor-Aβ15-21, an increase in the blue-
shift is commensurate with the formation of sub-visible, 
aggregates. Therefore, the data in Figure 4 suggest that for-
mation and association of early-stage fluor-Aβ15-21 aggre-
gates are dependent on the cellular environment. Poten-
tially these toxic species associate with dendrites but again 
we note the caveat of assigning sub-cellular structures 
based on morphology. This putative finding would how-
ever be consistent with the proposed synaptic binding sites 
and receptors for Aβ in neurons.29 The large magnitude 
edge-shift values do not necessarily correlate with large 
fluorescence intensity readings in Figure 4, as shown in 
Figure S9. That is, the extracted edge-shift values are not 
representing high local concentrations of the fluor-Aβ15-21, 
but more specifically capturing differences in early-stage 
aggregation state. Given the potential demonstrated with 
the fluor-Aβ15-21 we next examined a similar data-set with a 
longer form of Aβ, fluor-Aβ1-40 as shown in Figures 5-7 
Figure 5 shows the observed edge-shift for the fluor-Aβ1-
40 40 peptide but now aged over 24 hours at 25 °C, starting 
from the monomerized fluor-Aβ1-40. The corresponding 
raw excitation/emission spectra are shown in Figure S10. 
Figure 5A, inset shows the corresponding DLS profiles and 
Figure 5B shows the correlation between the observe edge-
shift and the size of aggregate. From Figure 5 the blue shift 
we observe with fluor-Aβ15-21 is essentially recapitulated for 
fluor-Aβ1-40 and even the relationship of aggregate size to 
the magnitude of edge-shift is qualitatively very similar 
(c.f. Figures 3B and 5B). We note that none of the time 
points we have tested show any significant emission arising 
from ThT binding (Figure S11) suggesting that, as with 
fluor-Aβ15-21 above, the edge-shift is only sensitive to the 
early-stage aggregates of Aβ. Moreover, similar to fluor-
Aβ15-21, we find that the magnitude of the edge shift
  
Figure 6. Mouse cortical neurons treated with aged 500 nM fluor-Aβ15-21 from Figure 5 at 0 hr (A), 1 hr (D) and 3 hrs (G).  The 
panels at right of each condition show a corresponding fluorescence emission image (λEx458nm; panels B, E and H) and the extracted 
edge shift value (λEx514nm - CSM λEx458nm; panels C, F, and I) overlaid as a false color map the corresponding image (panel A, D and 
G).  The scale bar at right corresponds to the ΔCSM values in the edge-shift false color maps. 
saturates as the hydrodynamic diameter approaches ~1 μm 
(Figure 5B). Finally, from Figure S12, we show that fluor-
Aβ1-40 is cytotoxic (based on MTT absorption to assess cy-
totoxicity) as one expects and compared to a scrambled 
version of fluor-Aβ15-21 (fluor-FKFQVAL), which does not 
show any significant edge-shift and is not predicted to ag-
gregate based on sequence analysis. 
We have imaged 500 nM fluor-Aβ1-40 in the presence of 
cortical neurons as in Figure 4, but using the fluor-Aβ1-40 
samples aged as in Figure 5. The resulting data for 0, 1 and 
3 hours are shown in Figure 6. At 6 and 24 hours we ob-
served only sparse fluorescence emission and we have not 
analysed the edge shift values for these data as we were not 
confident that the signal magnitude would allow us to ex-
tract accurate CSM values. From Figure 6 there is clearly 
association of fluor-Aβ1-40 with the neurons as with fluor-
Aβ15-21 in Figure 4. The magnitude of edge-shift is similar as 
with fluor-Aβ15-21, but now is red-shifted c.f. blue-shifted. 
The observed red edge-shift is also in contrast with the so-
lution studies with fluor-Aβ1-40 (Figure 5), where a blue-
shift is observed on aggregation. As with fluor-Aβ15-21 the 
large magnitude edge-shift values do not necessarily corre-
late with the highest intensity fluorescence regions. This 
confirms that the absolute magnitude of emission is not a 
good reporter of early stage aggregate association on cells. 
We note that the scrambled fluor-Aβ15-21 peptide shows 
hardly any emission under the same incubation times with 
the same cultured neurons (Figure S13) and is insufficient 
to generate a similar false color map of the edge-shift as in 
Figure 6. These data suggest that the observed edge shift in 
the presence of cultured neurons is not significantly con-
volved of non-specific binding. 
   
Figure 7.  Expanded view of images in Figure 6 (red dashed boxes). Panels correspond to the counterpart in Figure 6. Edge-shift 
scale bars are as in Figure 6. Cellular features discussed in the main text are highlighted with white dashed boxes. 
The local concentration of fluor-Aβ1-40 may be highly var-
iable depending on association with sub-cellular features 
and aggregation state. We do not find a significant change 
in the magnitude of the edge-shift value associated with 
different concentrations of the monomerised fluor-Aβ1-40 
(Figure S14), suggesting the observed changes in edge-shift 
shown in Figure 6 are not artifacts arising from changes in 
local concentration. 
We have also attempted to monitor the signal arising 
from fluor-Aβ1-40 aged in the presence of cells, however we 
found that the emission signal dissipated after 1 hr. Recent 
evidence has suggested that apoptosis-associated speck-
like protein containing a CARD (ASC) specks released by 
microglia, formed on Aβ deposition, increases the for-
mation of Aβ oligomers and aggregates.30 Potentially, the 
partially aggregated fluor-Aβ1-40 from Figure 5 gives im-
proved binding in the first instance, at least under the con-
ditions reported. A potential hypothesis therefore is that 
the sample aged in the presence of neurons are not induced 
to form aggregates because of a lack of ASC specks. 
The observation of a red versus a blue edge-shift is readily 
explained from our model fluorophore studies shown in 
Figure 2 and described above. These data show that a blue 
shift can transition to a red-shift, purely based on changes 
in solvent (environment) dielectric constant and this is 
consistent with the expected physical interpretation of 
edge shift phenomenon. Specifically, for the corresponding 
wavelength range studied in Figures 5, the data in Figure 2 
suggest a red shift occurs as the dielectric of the environ-
ment becomes smaller. That is, in the presence of neurons, 
the fluorophore molecular beacon is located in a relatively 
high dielectric environment for fluor-Aβ15-21 aggregates and 
in a relatively low dielectric environment for fluor-Aβ1-40 
aggregates.  
The dielectric constant inside a protein is generally much 
lower than at the proteins surface31 and so our data suggest 
the fluorophore molecular beacon is buried in protein ag-
gregates for fluor-Aβ1-40 and rather more solvent exposed 
for fluor-Aβ15-21. Indeed, recent studies using tryptophan as 
an intrinsic reporter of protein aggregation find a red edge-
shift,22 corroborating this notion. Taken together, our find-
ing of a red shift for fluor-Aβ1-40 in the presence of cells ver-
sus a blue-shift in solution potentially suggests an aggre-
gate conformation (dipole environment) that is unique to 
the combination of fluor-Aβ1-40 and the cellular microenvi-
ronment. That we find a different aggregate conformation 
in the presence of neurons versus buffered solution sug-
gests a hypothesis where the cellular environment drives a 
specific aggregation mechanism that is unique to the full 
length Aβ. We would stress that this represents a working 
 hypothesis, since only a discrete whole cell study could 
confidently validate the hypothesis. However, we believe 
these data are intriguing and provide the rationale for the 
exploration of the hypothesis.  
Membrane association has the potential to alter the en-
vironmental relaxation rate of the fluorophore.32 There-
fore, we wished to test if the immediate sub-cellular envi-
ronment is the origin of the edge-shift observed for Aβ1-40, 
instead of a specific conformational state of the aggregate. 
We have therefore incubated fluor-Aβ1-40 with nanodiscs, 
similar to previous studies33 and observed the edge-shift at 
zero and six hours as shown in Figure S15. From Figure S15 
we find the presence of the membrane environment has 
only a small effect on the magnitude of the observed edge 
shift and is trivial compared to the magnitude of the edge-
shift attributable to Aβ aggregation. Most importantly we 
do not observe that the presence of the membrane induces 
a red-shift in the data and so the observed red-shift for 
fluor-Aβ1-40 in the presence of cells is not a consequence of 
membrane association. That is, the membrane environ-
ment itself does not drive the aggregation inferred from 
the edge-shift data. It would seem likely this is driven by 
specific and possibly multiple protein-protein interactions. 
For example, the recent finding that ACS specks promote 
aggregate formation as discussed above. Potentially, the 
approach described here could be a useful platform to 
screen for important protein-protein interactions that give 
rise to Aβ aggregate binding and internalization. 
The time course study shown in Figure 6 reveals further 
details on the relationship between aggregate formation 
and localization. At 0 hrs (Figure 5A-C) there is a large 
edge-shift, which is diffusely spread across essentially all of 
the cells and sub-cellular features These data suggest the 
neurons induce relatively rapid aggregation of fluor-Aβ1-40 
(on the time-scale of preparation of the cells; ~minutes). 
At subsequent time points (1 hr, Figures D-F; 3 hrs, Figures 
G-I), the location of the aggregates becomes increasingly 
less diffuse and more localized, becoming almost entirely 
associated with putative cell soma with some discrete 
punctate labeling evident in putative axonal and peri-ax-
onal regions (based on morphology as above), shown in the 
expanded images in Figure 7. Indeed, it is the putative 
soma, in all cases, that appears to be coincident with the 
largest edge-shift value and the other sub-cellular environ-
ments (axons, dendrites) have little to no edge-shift. We 
note that the absolute fluorescence intensity at each time 
point is similar (Figure 6). These data therefore potentially 
suggest that over time, early-stage Aβ aggregates are inter-
nalized in the soma or rapidly trafficked to the cell soma. 
These findings are in stark contrast to the findings with the 
fluor-Aβ15-21 (Figure 4), where the soma appears to be rela-
tively free of aggregates, and the association is primarily 
with the axons/dendrites. Most importantly, these data 
very clearly illustrate the critical importance of considering 
both a full-length Aβ peptide and in the presence of an ap-
propriate cellular model when attempting to study early-
stage Aβ aggregation.  We would stress that we are cau-
tious in this interpretation of the results, not least because 
we cannot yet apply both the edge shift approach and cell 
staining as described above (though we anticipate this will 
be possible in the future). The most important finding 
from our data is that the edge shift value varies depending 
on sub-cellular location and appears to be linked to aggre-
gation state. Clearly, there is a great deal of further work 
required but the present study points to the potential util-
ity of this approach. 
Finally, the data in Figures 6 and 7 show an intriguing 
correlation between very large edge-shift values (pro-
gressed aggregation) and distinct cellular features that are 
not readily identifiable based simply on their morphology. 
Examples are highlighted in Figure 7 (white dashed boxes). 
These structures potentially represent shrunken cell bod-
ies consistent with labeling of apoptotic cell corpses. The 
co-localisation of highly aggregated Aβ with these features 
points to an important cellular context in which further 
studies could fruitfully be applied using the edge-shift ap-
proach to probe the mechanisms of Aβ induced neuronal 
cell death. 
 
CONLUSIONS 
We have demonstrated the edge-shift in the emission spec-
tra of fluorophore labeled proteins can report on very early 
stage (sub-visible) aggregates. We have applied this find-
ing to whole-cell microscopy experiments to monitor the 
formation of early-stage toxic aggregates of Aβ, at physio-
logical concentrations, in mouse primary cortical neurons. 
We find that the edge-shift is readily observable in the 
presence of a relevant cell type, and that the additional in-
formation from the microscopy platform potentially allows 
site specific measurement of the magnitude of the edge-
shift. Based on these preliminary studies, our data prompts 
the hypothesis that Aβ aggregation occurs in a site-specific 
manner on neuronal cells and that the neurons themselves, 
or their local environment, potentially drive the formation 
and specific conformation of the aggregates. We note that, 
at present, no other approach that we are aware of is able 
to detect and quantify these sub-visible aggregates on a mi-
croscopy platform using whole-cells, with a sensitivity that 
can detect differences in subcellular location.  
Clearly, a caveat with the approach is that it relies on label-
ling the protein of interest. Therefore, while we do not ad-
vocate this approach for diagnostic imaging, our findings 
point the way for studying the underlying cause of Aβ pa-
thology in AD as well as other neurotoxic protein aggre-
gates. Moreover, our study suggests the absolute magni-
tude of the edge-shift will be sensitive to (i) aggregate size, 
(ii) distribution of different aggregates and (iii) morphol-
ogy of the aggregates. Disentangling these contributions is 
the next step in developing the utility of this approach and 
our data point to the potentially very high discriminatory 
power. A part of this understanding will come from detail 
photo-physical studies of the edge-shift phenomenon it-
self. Finally, we see high potential for imaging at the super-
resolution level combined with bio-orthogonal labelling 
strategies to explore different cellular contexts in fine de-
tail. That is, we suggest that building the edge-shift ap-
 proach into other detection methodologies will signifi-
cantly enhance the utility of the methods used in isolation. 
Given that the edge-shift approach has the advantage that 
it does not require specialist instrumentation, and uses es-
tablished, readily available fluorescent probes we antici-
pate this should be an achievable goal in the short term. 
 
EXPERIMENTAL PROCEDURERS 
Antibody Labelling.  Antibodies (Rituximab and 
Nivolumab) were a kind gift from Bath ASU (Corsham, 
UK). Antibodies were labelled with Alexa Fluor® 488 C5-
Maleimide from Molecular Probes by Life Technologies or 
Fluorescein-5-Maleimide from Thermo Scientific.  To 1 mL 
of 50 mM Tris-HCl pH 8.0 buffer, 50 μL of antibody and 10 
μL (10 mg/mL) of 14 mM (Alexa 488) or 47 mM (fluores-
cein-5-maleimide) dye were added and the mixture was left 
at 5 ˚C for 1 hour.  The protein was then run through a PD-
10 desalting column and the absorbance was measured on 
a Varian Cary 50 Bio UV-Visible spectrophotometer (Var-
ian, Walnut Creek, CA, USA) to monitor antibody tagging.  
Aggregation was induced thermally for 30 minutes at 60 ˚C 
for Nivolumab and 70 ˚C for Rituximab. The antibodies 
were a kind gift from Bath ASU. 
Dynamic Light Scattering (DLS). Aggregation data was 
obtained in a 50 μL quartz cuvette on a Malvern Zetasizer 
Nano S (Malvern, Worcestershire, UK) to determine hy-
drodynamic radius.  Samples were left to equilibrate for 2 
minutes at 25 ˚C then measured in triplicate and averaged 
for reporting. 
Fluorescein Labelled Amyloid β Synthesis. Rink amide 
ChemMatrix™ resin was obtained from PCAS Biomatrix, 
Inc. (St.-Jean-sur-Richelieu, Canada); Fmoc l-amino acids 
and 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate or benzotriazol-1-yl-oxytripyrroli-
dinophosphonium hexafluorophosphate were obtained 
from AGTC Bioproducts (Hessle, UK); all other reagents 
were of peptide synthesis grade and obtained from Thermo 
Fisher Scientific (Loughborough, UK). Peptides were syn-
thesized on a 0.1 mmol scale on a PCAS ChemMatrix™ Rink 
amide resin using a Liberty Blue™ microwave peptide syn-
thesizer (CEM; Matthews, NC) employing Fmoc solid-
phase techniques with repeated steps of coupling, depro-
tection and washing (4 × 5 mL dimethylformamide).34 Cou-
pling was performed as follows: Fmoc amino acid (5 eq), 2-
(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hex-
afluorophosphate or benzotriazol-1-yl-oxytripyrrolidino-
phosphonium hexafluorophosphate (4.5 eq) and diisopro-
pylethylamine (10 eq) in dimethylformamide (5 mL) for 5 
min with 35-W microwave irradiation at 90 °C. Deprotec-
tion was performed as follows: 20% piperidine in dimethyl-
formamide for 5 min with 30-W microwave irradiation at 
80 °C. Following synthesis, the peptide was labelled with 
5(6)-carboxyfluorescein using a standard coupling step for 
20 min—and then cleaved it from the resin with concomi-
tant removal of side-chain-protecting groups by treatment 
with a cleavage mixture (10 mL) consisting of TFA (95%), 
triisopropylsilane (2.5%) and H2O (2.5%) for 4 h at room 
temperature. Suspended resin was removed by filtration, 
and the peptide was precipitated using three rounds of 
crashing in ice-cold diethyl ether, vortexing and centrifug-
ing. The pellet was then dissolved in 1:1 MeCN/H2O and 
freeze-dried. Purification was performed by RP-HPLC us-
ing a Phenomenex Jupiter Proteo (C18) reverse-phase col-
umn (4 μm, 90 Å, 10 mm inner diameter × 250 mm long). 
Eluents used were as follows: 0.1%TFA in H2O (a) and 0.1% 
TFA in MeCN (b). The peptide was eluted by applying a 
linear gradient (at 3 mL/min) of 5–70% B over 40 min. Frac-
tions collected were examined by electrospray MS, and 
those found to contain exclusively the desired product 
were pooled and lyophilized. Analysis of the purified final 
product by RP-HPLC indicated a purity of > 95%. Prior to 
running fluorescence measurements, fluorescein labelled 
Aβ15-21 and Aβ1-40 were monomerized using Zagorski 
methodology, followed by size exclusion on a PD-10 col-
umn to separate monomerized and aggregated material.35 
Fluorescence Measurements. REES measurements were 
carried out on a Perkin Elmer LS50B Luminescence Spec-
trometer (Perkin Elmer, Waltham, MA, USA) which was 
temperature regulated (±1 ˚C) using a circulating water 
bath.  Samples were allowed 5 minutes to equilibrate prior 
to measurements.  Measurements were obtained at 20 ˚C 
for labelled antibodies and 10 ˚C for fluorescein labelled 
amyloid β.  Excitation-emission slits were 4.0 nm for Alexa 
488 tagged antibodies and fluorescein tagged Aβ.  Formal-
dehyde studies for fluorescein tagged Aβ used excitation-
emission slit widths of 6.0 nm.  Alexa 488 emission was 
measured from 480 to 620 nm, with excitation scans taken 
every 2 nm from 410 to 460 nm.  Fluorescein emission was 
monitored from 535 to 650 nm, with excitation varied every 
2 nm from 400 to 520 nm.  All measurements were per-
formed in triplicate with the corresponding buffers also 
measured and subtracted from the spectra for each sample. 
For single wavelength excitation measurements, excita-
tion sources were 4.5 mW laser diode modules (405, 450, 
532 nm) and fluorescence emission was detected with a 
compact CCD CCS100 spectrometer (ThorLabs, Newton, 
NJ, USA). 
 The center of spectral mass (CSM) was calculated using: 
CSM =  
∑(𝑓𝑖𝑖 × 𝜆𝐸𝑚)
∑(𝑓𝑖)
  Eq 1 
where the measured fluorescence intensity is fi and the 
emission wavelength is λEm.  For measurements in buffered 
solution the concentration of protein/peptide used was 
typically between 1-2 μM and for microscopy experiments 
with neurons present, the concentration was 500 nM 
(buffer in both cases is PBS). 
High Resolution Fluorescence Microscopy. REES meas-
urements were carried out on a Leica SP8 confocal micro-
scope, Leica Microsystems with an Argon ion laser as the 
excitation source for 458, 476, 488, 496, and 514 nm with 
total power of 65 mW.  A 50 mW diode laser was used for 
λEx measurements at 405 nm.  Measurements were carried 
out at 37 ˚C measuring emission from 542.5 to 638.5 nm. 
As 405 nm gave a high amount of autofluorescence, CSM 
values were calculated for cells from 458 nm upward where 
 there is effectively no autofluorescence to be convolved in 
the signal. 
Primary Neuronal Cell Culture. Primary cortical neurons 
were prepared from CD1 mouse embryos in accordance 
with UK Home Office Guidelines as stated in the Animals 
(Scientific Procedures) Act 1986 using Schedule 1 proce-
dures approved by the University of Bath Animal Welfare 
and Ethical Review Body. Primary neurons were prepared 
essentially as described previously (22).Cortices were dis-
sected from 15-day-old CD1 mouse embryos, and were me-
chanically dissociated in PBS supplemented with 33 mM 
glucose, using a fire-polished glass Pasteur pipette.  Cells 
were plated into either 12- or 24-well Nunc tissue culture 
plates, previously coated with 20 µg/ml poly-D-lysine 
(Sigma). Neurons were cultured in Neurobasal medium 
(phenol red free) supplemented with 2 mM glutamine, 100 
µg/ml penicillin, 60 µg/ml streptomycin and B27 (all from 
Invitrogen), and incubated at 37°C, in high humidity with 
5% CO2. Under these growth conditions at 7-8 days in vitro 
(DIV) cells had a well-developed neuritic network and 
were 99% β-tubulin III positive and <1% GFAP positive. 
 
ASSOCIATED CONTENT  
Supporting Information. Absorption, emission and excita-
tion spectra corresponding to the EEM data shown, micros-
copy image showing whole cells and zoomed in views, scram-
bled peptide and nanodisc control experiments.  This material 
is available free of charge via the Internet at 
http://pubs.acs.org.  
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